BACE、BAI治疗支气管肺癌的近期疗效对比研究  

Comparative study of BACE、BAI effect of bronchial carcinoma

作　　者：李玉亮[1] 赵斌[2] 王永正[1] 邵广瑞[1] 张万明[1] 李征[1] 王振亭[2] 

机构地区：[1]山东大学第二医院介入诊疗中心,山东济南250033 [2]山东省医学影像学研究所,山东济南250021

出　　处：《医学影像学杂志》2004年第12期998-1000,共3页Journal of Medical Imaging

摘　　要：目的 :评价BACE与ABI治疗支气管肺癌的近期疗效。方法 :将 173例支气管肺癌分为A、B两组 ,A组 15 4例应用支气管动脉灌注药物治疗 ,B组 19例应用支气管动脉化学栓塞治疗。结果 :A、B两组总缓解率分别为 5 3 2 5 %和78 95 %两组比较差异有显著意义 (P <0 0 5 )。两组 1年生存率A(5 7 14 % )、B(73 6 8% )比较差异有显著性意义 (P <0 0 5 )。结论 :BACE治疗支气管肺癌的短期疗效优于BAI。Objective:To compare short-term effect of bronchial arterial chemoembolization (BACE) and bronchial arterial infusion (BAI) with bronchogenic carcinoma.[WT5”HZ]Methods:173 cases with bronchogenic carcinoma were divided into 2 groups. 154 cases were treated with BAI (group A), and 19 cases were treated with BACE(group B).Results:Entire response rate reached 53.25% in group A and reached 78.95% in group B, showing significant difference (P<0.05). When compared with the survival rate after one year (A:57.14%, B: 73.68%), that of group B was superior to group A.Conclusion:Compare to BAI, BACE showed higher entire response rate and 1-year survival rate. The short-term effect of BACE was superior to BAI for patients with bronchogenic carcinoma.

关 键 词：支气管肺癌 支气管动脉 栓塞 灌注 

分 类 号：R734.1[医药卫生—肿瘤] R815[医药卫生—临床医学]